Enhanced revascularization of the ischemic limb by angiogenic therapy.

Abstract

The data clearly indicate that an angiogenic growth factor, endothelial cell growth factor, promotes revascularization in this experimental ischemic hindlimb model, raising the possibility that in the future such agents might be of value in humans.